Treatment Indications: restoration of significant volume deficits and deep facial atrophy in high‑load zones (midface, cheeks, temples, chin);, 3D‑volumizing and structural support in supraperiosteal and deep subcutaneous layers; correction of severe facial contour deformities and asymmetry;, non‑surgical augmentation of cheekbones, chin, and jaw angle;, eshaping of facial architecture in age‑related volume loss; correction of deep depressions, folds, and atrophic scars with high lifting capacity
Release form: 1 × 1.0 mL pre‑filled sterile glass syringe
Compound: cross‑linked hyaluronic acid (non‑animal origin, produced via HICE technology for uniform particle size and reduced BDDE); lidocaine 0.3 %; phosphate‑buffered saline solution (pH ~7.0)
Concentration of GC: 20 mg/mL
Lidocaine: 0.3 %
Indications: volumizing and deep structural contouring requiring high G’ (elastic modulus) and shape retention;, restoration of major volume deficits with long‑term stability;, smoothing of deep folds, depressions, and scars;, providing pronounced lifting effect and minimal product migration due to high cohesivity;, expected effect duration ~12–18 months depending on injection site and individual factors
Order via WhatsApp
fillme-sale@ya.ru